The immune marker soluble urokinase plasminogen activator receptor is associated with new-onset diabetes in non-smoking women and men

S B Haugaard, O Andersen, T W Hansen, Jesper Eugen-Olsen, Allan René Linneberg, Sten Madsbad, M H Olsen, T Jørgensen, Knut Borch-Johnsen, J Jeppesen

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

To explore the putative association of new-onset diabetes and the soluble urokinase plasminogen activator receptor (suPAR), which is a new and stable plasma marker of immune function and low-grade inflammation. This association has been previously suggested by using the less sensitive International Classification of Disease system to detect incident diabetes in the Danish MONICA 10 cohort.
Original languageEnglish
JournalDiabetic Medicine
Volume29
Issue number4
Pages (from-to)479-87
Number of pages9
ISSN0742-3071
DOIs
Publication statusPublished - 2012

Keywords

  • Adult
  • Age Factors
  • Aged
  • Biological Markers
  • Cohort Studies
  • Diabetes Mellitus, Type 2
  • Female
  • Follow-Up Studies
  • Humans
  • Inflammation Mediators
  • Male
  • Middle Aged
  • Prognosis
  • Receptors, Urokinase Plasminogen Activator
  • Risk Assessment
  • Risk Factors
  • Sex Factors

Fingerprint

Dive into the research topics of 'The immune marker soluble urokinase plasminogen activator receptor is associated with new-onset diabetes in non-smoking women and men'. Together they form a unique fingerprint.

Cite this